Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115784895B enables metal-free arylamine synthesis. Reduces cost and lead time for pharmaceutical intermediates manufacturing with high purity.
Patent CN116813544B reveals metal-free heating method for quinoline. Reduces cost and improves supply chain reliability for pharma intermediates.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity triazole intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing partners.
Novel chiral induction method for Paxlovid intermediate. Reduces cost and improves safety. Reliable supply chain partner for pharmaceutical manufacturing.
Novel patent CN107011218A enables high ee value synthesis of chiral amines reducing steps and improving supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107936025B enables mild synthesis of chiral pyrazolidones. Eliminates heavy metals for cost reduction and supply chain reliability in pharmaceutical manufacturing.
Patent CN118126005B details metal-free synthesis of dihydrobenzofuran compounds offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Novel synthesis of Remdesivir intermediates via CN113214320A offers high purity and scalable manufacturing. Discover cost-effective supply chain solutions for antiviral API production.
Patent CN115286556B reveals green synthesis for indolinone esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110724164B discloses novel 3-substituted spiro ligands achieving 99% ee. Enables cost-effective API intermediate manufacturing with high TON.
Novel 4-step process for high-purity intermediates. Reduces complexity and enhances supply chain reliability for global manufacturers.
Patent CN112812084B reveals a cost-effective iron phthalocyanine catalyzed route for benzofuran intermediates, offering significant supply chain and purity advantages.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel palladium-catalyzed method offers significant cost reduction and high purity standards for global pharmaceutical intermediates manufacturing supply chains ensuring reliable delivery and operational efficiency.
Novel CuCl-catalyzed route for triazole arylamines. Enhances supply chain stability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel Pd-catalyzed method for 2-trifluoromethyl quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine. Cost-effective manufacturing solution.
Novel palladium-catalyzed carbonylation method offers cost reduction and scalable supply chain solutions for high-purity pharmaceutical intermediates manufacturing globally.
Novel chiral synthesis method offers high yield and enantioselectivity for antitumor drug intermediates, ensuring supply chain stability.
Patent CN106543081A details a palladium-catalyzed route for 1-difluoroalkyl isoquinolines, offering high yield and scalable manufacturing for pharmaceutical intermediates.
Patent CN109867632B reveals a safe copper-catalyzed route to 1,2,3-triazoles using diazonium salts, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.